NCT02349815View on ClinicalTrials.gov

JAYDESS Drug Utilization Study in Sweden

CompletedOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Contraception
Interventions
DRUG

Levonorgestrel (Jaydess, Skyla, BAY86-5028)

Women use Levonorgestrel (Jaydess, BAY86-5028) .

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Bayer

INDUSTRY